Discover 1,202 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,202
Active & Responsive
Phase 2b Study of EVO756 in Adults With Atopic Dermatitis
for
Atoptic Dermatitis
Location: Murfreesboro TN, Bowling Green KY, Clarksville IN,
Sponsor: Evommune, Inc.
Sex: All
Age: 18+
Code: NCT07150845
Phase2, Recruiting
Active & Responsive
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
for
Psoriasis, Overweight or Obesity
Location: Smyrna TN, Bowling Green KY, Douglasville GA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06857942
Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder (GAD)
Location: Franklin TN, Huntsville AL, Marietta GA, Cincinnati OH,
Sponsor: AbbVie
Sex: All
Age: 18 - 65
Code: NCT06846320
Phase2, Recruiting
Active & Responsive
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
for
Migraine
Location: Franklin TN, Huntsville AL, Chattanooga TN,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06417775
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
for
Progressive Pulmonary Fibrosis
Location: Franklin TN, Nashville TN, Birmingham AL, Atlanta GA,
Sponsor: Avalyn Pharma Inc.
Sex: All
Age: 18+
Code: NCT06329401
Phase2, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis